<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02704936</url>
  </required_header>
  <id_info>
    <org_study_id>505-BIO-035-MF</org_study_id>
    <nct_id>NCT02704936</nct_id>
  </id_info>
  <brief_title>Analysis of Lipid Profiles in Samples Sperm and Seminal Plasma Under Artificial Insemination</brief_title>
  <official_title>Analysis of Lipid Profiles in Samples Sperm and Seminal Plasma Under Artificial Insemination</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IVI Bilbao</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of the Basque Country (UPV/EHU)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>IVI Bilbao</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Identify, by Lipidomics approaches, biochemical markers of fertility / infertility in sperm&#xD;
      and seminal plasma linking the success or failure of the artificial insemination (IUI)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Analyze lipid profiles in samples of sperm and seminal plasma of three populations:&#xD;
&#xD;
        1. male sperm donors&#xD;
&#xD;
        2. men assigned to a program of assisted reproduction with normal sperm / slightly abnormal&#xD;
           successfully in the IUI;&#xD;
&#xD;
        3. attached to a program of assisted reproduction with male semen Normal / slightly&#xD;
           abnormal unsuccessfully in IUI&#xD;
&#xD;
      Establish partnerships between the composition of fatty acids, especially fatty acids&#xD;
      polyunsaturated (PUFA) of the omega-3 (w3) series of samples analyzed parameterssemen and&#xD;
      results of the IA to identify biochemical markers of fertility.&#xD;
&#xD;
      Assess markers found by checking the increase in the rate of success in the IA.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Difficulty recruiting patients&#xD;
  </why_stopped>
  <start_date type="Actual">December 2015</start_date>
  <completion_date type="Actual">October 2018</completion_date>
  <primary_completion_date type="Actual">October 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identify, by Lipidomics approaches, biochemical markers of fertility / infertility sperm and seminal plasma linking the success or failure of the artificial insemination</measure>
    <time_frame>18 months</time_frame>
    <description>Levels of docosahexaenoic acid (DHA) and acid eicosapentaenoic (EPA) in 42 semen samples:&#xD;
With positive pregnancy in any of the first 4 treatments of artificial insemination.&#xD;
Gestacion Negative in artificial insemination&#xD;
Assigned to the program-donors donation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Descriptive analysis of semen parameters versus DHA and EPA levels</measure>
    <time_frame>18 months</time_frame>
    <description>Correlation analysis of seminal variables:&#xD;
sperm count, motility and morphology percent compared to the levels of DHA and EPA obtained.&#xD;
Assuming normal distribution continuous variables, ANOVA test apply. If the normality assumption failed an Kruskal-Wallis test was applied.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Primary Infertility</condition>
  <arm_group>
    <arm_group_label>Male donor</arm_group_label>
    <description>42 samples of semen from male donor attached to a donation program Normal sperm count as WHO 2010.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IUI positive pregnancy</arm_group_label>
    <description>42 samples of semen from a program attached to patients for insemination Male indication Normal / slightly abnormal sperm count or infertility source unknown and have obtained positive pregnancy in any of the first 4 treatments IUI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IUI unsuccessful pregnancy</arm_group_label>
    <description>42 samples of semen from a program attached to patients for insemination Male indication Normal / slightly abnormal sperm count or infertility source unknown and after undergoing maximum 4 cycles have unsuccessfully IUI indication of IVF / ICSI.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who undergo cycles of artificial insemination with own semen. Donor semen samples&#xD;
        are intended for cycles of artificial insemination of donor Once the technical and knowing&#xD;
        the value of the ßhCG (indicating pregnancy hormone)determined up to a maximum of 4&#xD;
        treatments, the population for this study were divided into three groups&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria Group A women donor group&#xD;
&#xD;
          -  Fallopian unobstructed Men donor group&#xD;
&#xD;
          -  Appear as sperm donor&#xD;
&#xD;
          -  Age between 18-35 years&#xD;
&#xD;
          -  Sexual abstinence 3-5 days&#xD;
&#xD;
        Exclusion Criteria Group A:&#xD;
&#xD;
          -  Uterine malformations (fibroids, adenomyosis, uterine malformations or acquired&#xD;
             congenital) and fallopian tubes (tubal occlusion)&#xD;
&#xD;
          -  Obesity BMI (Body Mass Index)&gt; 30 kg / m2&#xD;
&#xD;
          -  Presence of altered tubal toxic habits (smoking&gt; 15 cigarettes per day, alcohol or&#xD;
             drug abuse).&#xD;
&#xD;
        Inclusión / Exclusion Criteria Group B and C:&#xD;
&#xD;
          -  ≤ 38 years&#xD;
&#xD;
          -  Natural cycles and stimulated&#xD;
&#xD;
          -  The criteria inclusion / exclusion group A&#xD;
&#xD;
          -  Time sterility not exceeding three years.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcos Ferrando, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IVI Bilbao</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IVI Bilbao</name>
      <address>
        <city>Leioa</city>
        <state>Vizcaya</state>
        <zip>48940</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 17, 2016</study_first_submitted>
  <study_first_submitted_qc>March 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2016</study_first_posted>
  <last_update_submitted>September 2, 2021</last_update_submitted>
  <last_update_submitted_qc>September 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

